Please login to the form below

Not currently logged in
Email:
Password:

Label change for Lilly's Livalo

The US Food and Drug Administration has said Eli Lilly & Company can update the label of cholesterol drug Livalo to remove a warning against the use of the drug together with HIV treatment lopinavir/ritonavir

The US Food and Drug Administration (FDA) has said Eli Lilly & Company can update the label of cholesterol drug Livalo (pitavastatin) to remove a warning against the use of the drug together with HIV treatment lopinavir/ritonavir.

The decision follows a study investigating the effects on patients when co-administered both treatments.

Data from the study demonstrated that there was no significant impact on the blood levels of participants, with minimal interaction between the two drugs.

"Livalo showed minimal drug-drug interactions with a common antiretroviral therapy HIV patients need to fight the disease," said Dr Judith Aberg, director of Virology, Bellevue Hospital Center and director, Division of Infectious Diseases and Immunology, NYU School of Medicine. "For a patient population that is taking multiple medications, this is exciting news."

Drugs to lower cholesterol, such as Livalo, are often prescribed to patients with HIV, with elevated cholesterol a complication associated with both the virus itself and antiretroviral therapies.

18th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics